Of the remaining nine tumours with loss of MSH6 expression, eight tumours also showed loss of MSH2 expression of which two were difficult to interpret and possibly showed loss of PMS2 expression as well, suggesting the presence of an as yet undetected MSH2 (or PMS2) germline mutation. This evidence concerns the gene MSH6 and neoplasm.